IP Library Granted Patent US 7,345,217
Granted Patent B2
US 7,345,217 · App. 10/412,699 · Granted Mar 18, 2008

Polynucleotides and polypeptides in plants

Assignee: Mendel Biotechnology, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,345,217
App. No.
10/412,699
Granted
Mar 18, 2008
Kind
B2
Abstract

The invention relates to plant transcription factor polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference plant. Sequence information related to these polynucleotides and polypeptides can also be used in bioinformatic search methods and is also disclosed.

Claims (39)

1. A transgenic plant that has greater tolerance to cold than a control plant as the result of expressing a polypeptide that regulates transcription in the transgenic plant; wherein the transgenic plant comprises a recombinant polynucleotide encoding a polypeptide, and wherein the polypeptide comprises a conserved Myb DNA-binding domain with at least 95% sequence identity to the conserved Myb DNA-binding domain of amino acid coordinates 13-116 of SEQ ID NO: 438, and wherein the conserved Myb DNA-binding domain binds DNA.

2. The transgenic plant of claim 1 , wherein the transgenic plant is more tolerant to 8° C. during its germination than the control plant.

3. The transgenic plant of claim 1 , wherein the transgenic plant is more tolerant to 8° C. during its development than the control plant.

4. The transgenic plant of claim 1 , wherein the conserved domain has at least 98% sequence identity with the conserved domain of amino acid coordinates 13-116 of SEQ ID NO: 438.

5. The transgenic plant of claim 1 , wherein the polypeptide is encoded by a nucleic acid that is derived from a monocotyledonous plant.

6. The transgenic plant of claim 5 , wherein the transgenic plant is a eudicot.

7. The transgenic plant of claim 1 , wherein the polypeptide is encoded by a nucleic acid that is derived from a eudicot plant.

8. The transgenic plant of claim 7 , wherein the transgenic plant is monocotyledonous.

9. The transgenic plant of claim 1 , wherein the recombinant polynucleotide further comprises a constitutive, inducible, or tissue-specific promoter that regulates expression of the polypeptide.

10. An expression vector for expression of a polypeptide that confers greater cold tolerance in a transgenic plant than the cold tolerance of a control plant wherein the expression vector comprises:

(1) a constitutive, inducible, or tissue-specific promoter; and

(2) a recombinant polynucleotide encoding the polypeptide that regulates transcription, wherein the polypeptide comprises a conserved Myb DNA-binding domain having at least 95% sequence identity with the conserved Myb DNA-binding domain of amino acid coordinates 13-116 of SEQ ID NO: 438 and wherein the conserved Myb DNA-binding domain binds DNA; wherein the constitutive, inducible, or tissue-specific promoter regulates expression of the polypeptide.

11. The expression vector of claim 10 , wherein the conserved domain of the polypeptide has at least 98% sequence identity with the conserved domain of amino acid coordinates 13-116 of SEQ ID NO: 438.

12. The expression vector of claim 10 , wherein the recombinant polynucleotide comprises SEQ ID NO: 437.

13. A host plant cell comprising the expression vector of claim 10 .

14. A method for producing a transgenic plant having greater tolerance to cold as compared to a control plant as the result of expressing a polypeptide that regulates transcription in the transgenic plant, wherein the control plant is without the recombinant polynucleotide, the method comprising:

(a) providing an expression vector encoding the polypeptide, wherein the polypeptide comprises a conserved Myb DNA-binding domain having at least 95% sequence identity with the conserved Myb DNA-binding domain of amino acid coordinates 13-116 of SEQ ID NO: 438 and wherein the conserved Myb DNA-binding domain binds DNA; and

(b) introducing the expression vector into a first target plant to produce the transgenic plant, or introducing the expression vector into a cell of a second target plant, and growing the cell into the transgenic plant.

15. The method of claim 14 , wherein the conserved domain of the polypeptide has at least 98% sequence identity with the conserved domain of amino acid coordinates 13-116 of SEQ ID NO: 438.

16. The method of claim 14 , wherein the expression vector comprises SEQ ID NO: 437.

17. The method of claim 14 , wherein:

the transgenic plant is selected by comparing cold tolerance of the transgenic plant with cold tolerance of the control plant.

18. The method of claim 14 , wherein the transgenic plant is more tolerant to 8° C. during its germination than the control plant.

19. The method of claim 14 , wherein the transgenic plant is more tolerant to 8° C. during its development than the control plant.

20. The method of claim 14 , wherein the expression vector further comprises a constitutive, inducible, or tissue-specific promoter that regulates expression of the polypeptide.

21. A transgenic seed comprising an expression vector for expression of a polypeptide that confers greater cold tolerance in a transgenic plant relative to a control plant, wherein the expression vector comprises:

(1) a constitutive, inducible, or tissue-specific promoter; and

(2) a recombinant polynucleotide encoding the polypeptide that regulates transcription, wherein the polypeptide comprises a conserved Myb DNA-binding domain having at least 95% sequence identity with the conserved Myb DNA-binding domain of amino acid coordinates 13-116 of SEQ ID NO: 438 and wherein the conserved Myb DNA-binding domain binds DNA; and wherein the constitutive, inducible, or tissue-specific promoter regulates expression of the polypeptide.

22. The transgenic seed of claim 21 , wherein the conserved domain of the polypeptide has at least 98% sequence identity with a conserved domain of amino acid coordinates 13-116 of SEQ ID NO: 438.

23. A transgenic plant that has greater tolerance to cold as compared to a control plant as the result of expressing a polypeptide that regulates transcription in the transgenic plant, wherein the transgenic plant comprises:

a recombinant polynucleotide encoding a polypeptide that regulates transcription; and the polypeptide comprises the conserved Myb DNA-binding domain of amino acid coordinates 13-116 of SEQ ID NO:438 and wherein the conserved Myb DNA-binding domain binds DNA.

24. The transgenic plant of claim 23 , wherein the transgenic plant is more tolerant to 8° C. during its germination than the control plant.

25. The transgenic plant of claim 23 , wherein the transgenic plant is more tolerant to 8° C. during its development than the control plant.

26. A method for producing a transgenic plant having greater tolerance to cold as compared to a control plant as the result of expressing a polypeptide that regulates transcription in the transgenic plant, wherein the control plant is without the recombinant polynucleotide, the method comprising:

(a) providing an expression vector encoding a polypeptide comprising the Myb DNA-binding domain of amino acid coordinates 13-116 of SEQ ID NO: 438 and wherein the conserved Myb DNA-binding domain binds DNA; and

(b) introducing the expression vector into a plant or a cell of a plant, thereby producing the transgenic plant.

27. The method of claim 26 , wherein the expression vector further comprises a constitutive, inducible, or tissue-specific promoter that regulates expression of the polypeptide.

28. The method of claim 26 , wherein the transgenic plant is more tolerant to 8° C. during its germination than the control plant.

29. The method of claim 26 , wherein the transgenic plant is more tolerant to 8° C. during its development than the control plant.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2003
From: ZHANG, JAMES; HEARD, JACQUELINE E.; ADAM, LUC J.; REUBER, T. LYNNE; CREELMAN, ROBERT A.; RATCLIFFE, OLIVER; KIMIMOTO, RODERICK; SHERMAN, BRADLEY K.; FROMM, MICHAEL E.; RIECHMANN, JOSE LUIS; YU, GUO-LIANG; PINEDA, OMAIRA; DUBELL, ARNOLD N.; KEDDIE, JAMES S.; JIANG, CAI-ZHONG; PILGRIM, MARSHA L.; SAMAHA, RAYMOND S.; BROUN, PIERRE E.
To: MENDEL BIOTECHNOLOGY, INC.
Reel/Frame 014429/0465 →
Continuity (55)
Continuation In Part 1037478000 · Feb 25, 2003
Continuation In Part 1030226700 · Nov 22, 2002
Continuation In Part 1029540300 · Nov 15, 2002
Continuation In Part 1029062700 · Nov 7, 2002
Continuation In Part 1028626400 · Nov 1, 2002
Continuation In Part 1027853600 · Oct 22, 2002
Continuation In Part 1027817300 · Oct 21, 2002
Continuation In Part 1022506600 · Aug 9, 2002
Continuation In Part 1022506800 · Aug 9, 2002
Continuation In Part 1022506700 · Aug 9, 2002
Continuation In Part 1017146800 · Jun 14, 2002
Continuation In Part 0995813100 · Jan 30, 2002
Continuation In Part 0993445500 · Aug 22, 2001
Continuation In Part 0983794400 · Apr 18, 2001
Continuation In Part 0981914200 · Mar 27, 2001
Continuation In Part 0971399400
Division 0953303000 · Mar 22, 2000
Division 0953339200 · Mar 22, 2000
Continuation In Part 0953302900 · Mar 22, 2000
Division 0953259100 · Mar 22, 2000
Division 0953364800 · Mar 22, 2000
Division 0950672000 · Feb 17, 2000
Continuation In Part 0948937600 · Jan 21, 2000
Division 0939451900 · Sep 13, 1999
Provisional Application 6043416600 · Dec 17, 2002
Provisional Application 6033869200 · Dec 11, 2001
Provisional Application 6033604900 · Nov 19, 2001
Provisional Application 6031084700 · Aug 9, 2001
Provisional Application 6033869200 · Dec 11, 2001
Provisional Application 6033604900 · Nov 19, 2001
Provisional Application 6031084700 · Aug 9, 2001
Provisional Application 6033869200 · Dec 11, 2001
Provisional Application 6033604900 · Nov 19, 2001
Provisional Application 6031084700 · Aug 9, 2001
Provisional Application 6022743900 · Aug 22, 2000
Provisional Application 6022743900 · Aug 22, 2000
Provisional Application 6019789900 · Apr 17, 2000
Provisional Application 6016622800 · Nov 17, 1999
Provisional Application 6012815300 · Apr 7, 1999
Provisional Application 6012581400 · Mar 23, 1999
Provisional Application 6016265600 · Nov 1, 1999
Provisional Application 6016114300 · Oct 22, 1999
Provisional Application 6014415300 · Jul 15, 1999
Provisional Application 6013513400 · May 20, 1999
Provisional Application 6012945000 · Apr 15, 1999
Provisional Application 6012427800 · Mar 11, 1999
Provisional Application 6012103700 · Feb 22, 1999
Provisional Application 6012088000 · Feb 18, 1999
Provisional Application 6011684100 · Jan 22, 1999
Provisional Application 6011340900 · Dec 22, 1998
Provisional Application 6010873400 · Nov 17, 1998
Provisional Application 6010331200 · Oct 6, 1998
Provisional Application 6010134900 · Sep 22, 1998
Related Publication 20040045049A1 · Mar 4, 2004
Related Publication 20070061911A9 · Mar 15, 2007